Format

Send to

Choose Destination
Clin Microbiol Rev. 2017 Jul;30(3):811-825. doi: 10.1128/CMR.00109-16.

Strategies for Prevention and Treatment of Trichomonas vaginalis Infections.

Author information

1
Institut Galien Paris-Sud and Institut Universitaire de France, UMR CNRS 8612, Université Paris-Sud, Université Paris-Saclay, Faculté de Pharmacie, Châtenay-Malabry, France kawthar.bouchemal@u-psud.fr.
2
Biomolécules: Conception, Isolement, Synthèse (BioCIS)-Chimiothérapie Antiparasitaire, UMR CNRS 8076, Université Paris-Sud, Université Paris-Saclay, Faculté de Pharmacie, Châtenay-Malabry, France.

Abstract

The last estimated annual incidence of Trichomonas vaginalis worldwide exceeds that of chlamydia and gonorrhea combined. This critical review updates the state of the art on advances in T. vaginalis diagnostics and strategies for treatment and prevention of trichomoniasis. In particular, new data on treatment outcomes for topical administration of formulations are reviewed and discussed.

KEYWORDS:

Trichomonas vaginalis

PMID:
28539504
PMCID:
PMC5475227
DOI:
10.1128/CMR.00109-16
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center